越来越多创始人接受被并购的命运。日前，第三方医学检验实验室（ICL）特检上市公司康圣环球发布公告称，拟以总代价3130万美元（约合人民币2.2亿元）收购肿瘤早检企业基准医疗100%股权权益。尽管交易规模不大，但依旧留给外界深刻印象。究其原因，一方面，买卖双方在细分赛道颇具知名度，撕开肿瘤早筛市场整合的一道口子；另一方面，相较于基准医疗此前四轮融资获得的8300万美元（约合人民币5.8亿元）融资额，...
Source Link越来越多创始人接受被并购的命运。日前，第三方医学检验实验室（ICL）特检上市公司康圣环球发布公告称，拟以总代价3130万美元（约合人民币2.2亿元）收购肿瘤早检企业基准医疗100%股权权益。尽管交易规模不大，但依旧留给外界深刻印象。究其原因，一方面，买卖双方在细分赛道颇具知名度，撕开肿瘤早筛市场整合的一道口子；另一方面，相较于基准医疗此前四轮融资获得的8300万美元（约合人民币5.8亿元）融资额，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.